Concepedia

Publication | Closed Access

Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.

13

Citations

0

References

2016

Year

Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Masato Takaoka, Tsukie Kin Tsukuda, Kazuki Anabuki, Shigeo Kawase, Shintaro Miyamoto, Hiroshi Ohnishi, Nobuo Hatakeyama,
PubMed

Abstract

Weekly administration of PTX combined with CBDCA plus BEV therapy was effective, and well-tolerated by advanced NSCLC patients.